These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36801204)

  • 1. Exploring the mediating role of baseline urinalysis results on demographic characteristics and stimulant use disorder treatment outcomes.
    Smith CL; Miguel AQ; Keever A; Bowden T; Burduli E; Roll J; McPherson SM
    J Subst Use Addict Treat; 2023 Aug; 151():208962. PubMed ID: 36801204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining Longitudinal Stimulant Use and Treatment Attendance as Parallel Outcomes in Two Contingency Management Randomized Clinical Trials.
    McPherson S; Brooks O; Barbosa-Leiker C; Lederhos C; Lamp A; Murphy S; Layton M; Roll J
    J Subst Abuse Treat; 2016 Feb; 61():18-25. PubMed ID: 26456717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome.
    Saxon AJ; Wells EA; Fleming C; Jackson TR; Calsyn DA
    Addiction; 1996 Aug; 91(8):1197-209. PubMed ID: 8828247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validating the clinical relevance of alternative stimulant use treatment outcome measures by examining their association with 3-month follow-up outcomes.
    Miguel AQC; Smith CL; Burduli E; Roll JM; McPherson SM
    Exp Clin Psychopharmacol; 2021 Jun; 29(3):288-293. PubMed ID: 34264739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulant abuser groups to engage in 12-step: a multisite trial in the National Institute on Drug Abuse Clinical Trials Network.
    Donovan DM; Daley DC; Brigham GS; Hodgkins CC; Perl HI; Garrett SB; Doyle SR; Floyd AS; Knox PC; Botero C; Kelly TM; Killeen TK; Hayes C; Kau'i Baumhofer N; Seamans C; Zammarelli L
    J Subst Abuse Treat; 2013 Jan; 44(1):103-14. PubMed ID: 22657748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applying behavioral activation to sustain and enhance the effects of contingency management for reducing stimulant use among individuals with HIV infection.
    Mimiaga MJ; Closson EF; Pantalone DW; Safren SA; Mitty JA
    Psychol Health Med; 2019 Mar; 24(3):374-381. PubMed ID: 30211620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptation of contingency management for stimulant use disorder during the COVID-19 pandemic.
    Zastepa E; Sun JC; Clune J; Mathew N
    J Subst Abuse Treat; 2020 Nov; 118():108102. PubMed ID: 32854983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abstinence-based incentives in methadone maintenance: interaction with intake stimulant test results.
    Stitzer ML; Peirce J; Petry NM; Kirby K; Roll J; Krasnansky J; Cohen A; Blaine J; Vandrey R; Kolodner K; Li R
    Exp Clin Psychopharmacol; 2007 Aug; 15(4):344-50. PubMed ID: 17696681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between pre-treatment drug use and heterogeneity of psychiatric diagnosis predicts outcomes in outpatients with co-occurring disorders.
    Oluwoye O; Hirchak K; Leickly E; Skalisky J; McPherson S; Srebnik D; Roll JM; Ries RK; McDonell MG
    Psychiatry Res; 2018 Feb; 260():233-235. PubMed ID: 29220679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals.
    Rawson RA; McCann MJ; Flammino F; Shoptaw S; Miotto K; Reiber C; Ling W
    Addiction; 2006 Feb; 101(2):267-74. PubMed ID: 16445555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness.
    McDonell MG; Srebnik D; Angelo F; McPherson S; Lowe JM; Sugar A; Short RA; Roll JM; Ries RK
    Am J Psychiatry; 2013 Jan; 170(1):94-101. PubMed ID: 23138961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can a simple urinalysis predict the causative agent and the antibiotic sensitivities?
    Waseem M; Chen J; Paudel G; Sharma N; Castillo M; Ain Y; Leber M
    Pediatr Emerg Care; 2014 Apr; 30(4):244-7. PubMed ID: 24651215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Stimulant Treatment and Substance Use Through Adolescence Into Early Adulthood.
    Molina BSG; Kennedy TM; Howard AL; Swanson JM; Arnold LE; Mitchell JT; Stehli A; Kennedy EH; Epstein JN; Hechtman LT; Hinshaw SP; Vitiello B
    JAMA Psychiatry; 2023 Sep; 80(9):933-941. PubMed ID: 37405756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of stimulant abuse treatment outcomes in severely mentally ill outpatients.
    Angelo FN; McDonell MG; Lewin MR; Srebnik D; Lowe J; Roll J; Ries R
    Drug Alcohol Depend; 2013 Jul; 131(1-2):162-5. PubMed ID: 23273776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial interventions for stimulant use disorder.
    Minozzi S; Saulle R; Amato L; Traccis F; Agabio R
    Cochrane Database Syst Rev; 2024 Feb; 2(2):CD011866. PubMed ID: 38357958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized Controlled Trial Comparing Exercise to Health Education for Stimulant Use Disorder: Results From the CTN-0037 STimulant Reduction Intervention Using Dosed Exercise (STRIDE) Study.
    Trivedi MH; Greer TL; Rethorst CD; Carmody T; Grannemann BD; Walker R; Warden D; Shores-Wilson K; Stoutenberg M; Oden N; Silverstein M; Hodgkins C; Love L; Seamans C; Stotts A; Causey T; Szucs-Reed RP; Rinaldi P; Myrick H; Straus M; Liu D; Lindblad R; Church T; Blair SN; Nunes EV
    J Clin Psychiatry; 2017; 78(8):1075-1082. PubMed ID: 28199070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An economic evaluation of a contingency-management intervention for stimulant use among community mental health patients with serious mental illness.
    Murphy SM; McDonell MG; McPherson S; Srebnik D; Angelo F; Roll JM; Ries RK
    Drug Alcohol Depend; 2015 Aug; 153():293-9. PubMed ID: 26026494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic, Clinical, and Sociodemographic Factors Associated With Stimulant Treatment Outcomes in ADHD.
    Brikell I; Wimberley T; Albiñana C; Pedersen EM; Vilhjálmsson BJ; Agerbo E; Demontis D; Børglum AD; Schork AJ; LaBianca S; Werge T; Mors O; Hougaard DM; Thapar A; Mortensen PB; Dalsgaard S
    Am J Psychiatry; 2021 Sep; 178(9):854-864. PubMed ID: 34154395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.